BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31020311)

  • 1. Cancer Chemoprevention: Preclinical In Vivo Alternate Dosing Strategies to Reduce Drug Toxicities.
    Mohammed A; Fox JT; Miller MS
    Toxicol Sci; 2019 Aug; 170(2):251-259. PubMed ID: 31020311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The retinoids and cancer prevention mechanisms.
    Dragnev KH; Rigas JR; Dmitrovsky E
    Oncologist; 2000; 5(5):361-8. PubMed ID: 11040271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of chemoprevention in cancer control.
    Greenwald P; Kelloff GJ
    IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of chemopreventive agents for lung and upper aerodigestive tract cancers.
    Kelloff GJ; Boone CW; Steele VK; Perloff M; Crowell J; Doody LA
    J Cell Biochem Suppl; 1993; 17F():2-17. PubMed ID: 8412195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer chemoprevention: progress and promise.
    Kelloff GJ; Sigman CC; Greenwald P
    Eur J Cancer; 1999 Dec; 35(13):1755-62. PubMed ID: 10673988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer chemoprevention drug targets.
    Krishnan K; Campbell S; Abdel-Rahman F; Whaley S; Stone WL
    Curr Drug Targets; 2003 Jan; 4(1):45-54. PubMed ID: 12528989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New agents for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet RA; Doody LA; Malone WF; Hawk ET; Sigman CC
    J Cell Biochem Suppl; 1996; 26():1-28. PubMed ID: 9154166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon cancer: preventive agents and the present status of chemoprevention.
    Half E; Arber N
    Expert Opin Pharmacother; 2009 Feb; 10(2):211-9. PubMed ID: 19236194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria of evidence to move potential chemopreventive agents into late phase clinical trials.
    Kelly RJ; Lopez-Chavez A; Szabo E
    Curr Drug Targets; 2011 Dec; 12(13):1983-8. PubMed ID: 21158704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in clinical chemoprevention.
    Kelloff GJ; Hawk ET; Karp JE; Crowell JA; Boone CW; Steele VE; Lubet RA; Sigman CC
    Semin Oncol; 1997 Apr; 24(2):241-52. PubMed ID: 9129692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should we move the field of chemopreventive agent development forward in a productive manner?
    Meyskens FL; Szabo E
    Recent Results Cancer Res; 2005; 166():113-24. PubMed ID: 15648187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the effects of isothiocyanates on chemotherapeutic drugs.
    Minarini A; Milelli A; Fimognari C; Simoni E; Turrini E; Tumiatti V
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):25-38. PubMed ID: 24087843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of epithelial cancers.
    Shureiqi I; Brenner DE
    Curr Opin Oncol; 1999 Sep; 11(5):408-13. PubMed ID: 10505781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer chemoprevention by carotenoids.
    Tanaka T; Shnimizu M; Moriwaki H
    Molecules; 2012 Mar; 17(3):3202-42. PubMed ID: 22418926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol design considerations that relate to demonstrating the safety and effectiveness of chemopreventive agents.
    Johnson KA; Beitz J; Justice R; Schmidt W; Andrews P; DeLap R
    J Cell Biochem Suppl; 1997; 27():1-6. PubMed ID: 9591186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications.
    Chhabra G; Singh CK; Ndiaye MA; Fedorowicz S; Molot A; Ahmad N
    Cancer Lett; 2018 May; 422():9-18. PubMed ID: 29471004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ellagitannins in Cancer Chemoprevention and Therapy.
    Ismail T; Calcabrini C; Diaz AR; Fimognari C; Turrini E; Catanzaro E; Akhtar S; Sestili P
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27187472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Phytochemicals in Cancer Prevention.
    Ranjan A; Ramachandran S; Gupta N; Kaushik I; Wright S; Srivastava S; Das H; Srivastava S; Prasad S; Srivastava SK
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.